Use of aldosterone antagonists at discharge after myocardial infarction: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry–Get with the Guidelines (GWTG)

Background Aldosterone antagonists (AldA) improve survival after myocardial infarction (MI) in patients with left ventricular systolic dysfunction (ejection fraction [EF]

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2013-10, Vol.166 (4), p.709-715
Hauptverfasser:	Rao, Krishnasree K., MD, Enriquez, Jonathan R., MD, de Lemos, James A., MD, Alexander, Karen P., MD, MHS, Chen, Anita Y., MS, McGuire, Darren K., MD, MHSc, Fonarow, Gregg C., MD, Das, Sandeep R., MD, MPH
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cardiovascular Clinical outcomes Comorbidity Diabetes Dose-Response Relationship, Drug Drug therapy Female Follow-Up Studies Guideline Adherence Health maintenance organizations Heart attacks Heart failure HMOs Hospitalization Hospitals Humans Male Middle Aged Mineralocorticoid Receptor Antagonists - therapeutic use Myocardial Infarction - drug therapy Myocardial Infarction - mortality Patient Discharge Patients Registries Retrospective Studies Risk Factors Studies Surgery Survival Rate - trends Treatment Outcome United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Aldosterone antagonists (AldA) improve survival after myocardial infarction (MI) in patients with left ventricular systolic dysfunction (ejection fraction [EF]
ISSN:	0002-8703 1097-6744
DOI:	10.1016/j.ahj.2013.06.020